Ovarian Cancer | Tumor

Oral Contraceptives May Reduce Endometrial, Ovarian Cancer Risk Decades After Stopping Use

January 22nd 2021, 2:00pm


Women who reported using oral contraceptives had a decreased risk of endometrial and ovarian cancer, compared to those who never used the hormone medications. The data also indicated the association extended up to three decades after patients stopped using the contraceptives.

Celebrating A ‘Cancerversary’ In A COVID-19 World

January 16th 2021, 8:00pm


It’s okay for me to not feel like celebrating my 5-year cancerversary in a world that is upside down and backward because of COVID-19. Yes, I’m grateful and blessed, but I’m not bullet-proof. I’m human. I don’t have to feel guilty. None of us do.

Actor Scott Foley Offers Hope, Raises Awareness to Women with Ovarian Cancer

January 8th 2021, 2:00pm


In an interview with CURE®, the “Felicity” and “Scandal” actor spoke about his experience as a caregiver to his mother, and why women should not just watch and wait for their ovarian cancer to recur.

Proper Staging of Early-Stage Ovarian Cancer Before Treatment Provides Critical Information for Potentially Improved Outcomes

January 5th 2021, 7:00pm


A gynecologic oncology expert from the University of California, Davis reviewed early-stage ovarian cancer and the importance of knowing what options are available before, during and after treatment.

7 Ovarian Cancer News and Updates That Patients May Have Missed in 2020

January 4th 2021, 10:00pm


A roundup of some ovarian cancer news and updates that occurred in 2020 that patients may have missed.

Possible Future Treatment Shows Better Quality of Life in Patients with Ovarian Cancer

December 28th 2020, 10:00pm


Women with ovarian cancer report a better quality of life when treated with a combination of Keytruda, Avastin and oral metronomic cyclophosphamide.

Keytruda Combo Therapy Demonstrates Clinical Benefit and Durable Treatment Response in Recurrent Ovarian Cancer

December 22nd 2020, 10:00pm


Keytruda (pembrolizumab), Avastin (bevacizumab) and cyclophosphamide contributed to a clinical benefit in 95% of women in the trial and a durable treatment response of 12 months or longer in 25% of women.

Ovarian Cancer Heroes 2020

October 17th 2020, 10:00pm


Watch the entire Ovarian Cancer Heroes program right here!

CURE®’s Annual Ovarian Cancer Heroes Program Goes Virtual Amid COVID-19 to Honor Three Women Who Have Dedicated Their Lives to Patients with Gynecologic Cancer

October 17th 2020, 1:00pm


An oncology nurse, patient turned advocate and cancer biologist were honored during CURE®’s third annual Ovarian Cancer Heroes program where they got to share messages of resiliency with a virtual audience.

How COVID-19 Robs Patients with Cancer of Their Precious Time

October 6th 2020, 4:00pm


Time is a valuable commodity, especially for patients with cancer who may find themselves with limited time or limited free time to enjoy the things they loved prior to their cancer. But the COVID-19 pandemic is robbing patients of that precious time.